1. Home
  2. GTE vs KPTI Comparison

GTE vs KPTI Comparison

Compare GTE & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gran Tierra Energy Inc.

GTE

Gran Tierra Energy Inc.

N/A

Current Price

$4.84

Market Cap

163.1M

Sector

Energy

ML Signal

N/A

Logo Karyopharm Therapeutics Inc.

KPTI

Karyopharm Therapeutics Inc.

N/A

Current Price

$6.68

Market Cap

148.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GTE
KPTI
Founded
2003
2008
Country
Canada
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
163.1M
148.0M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
GTE
KPTI
Price
$4.84
$6.68
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$22.17
AVG Volume (30 Days)
589.5K
401.4K
Earning Date
02-23-2026
02-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$611,444,000.00
$142,530,000.00
Revenue This Year
$4.87
$3.82
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.09
$3.51
52 Week High
$8.04
$10.80

Technical Indicators

Market Signals
Indicator
GTE
KPTI
Relative Strength Index (RSI) 62.44 42.84
Support Level $4.69 $6.49
Resistance Level $5.12 $8.95
Average True Range (ATR) 0.24 0.59
MACD 0.09 -0.16
Stochastic Oscillator 75.45 4.07

Price Performance

Historical Comparison
GTE
KPTI

About GTE Gran Tierra Energy Inc.

Gran Tierra Energy Inc is an independent energy company. The company, along with its subsidiaries, is focused on oil and gas exploration and production, with assets in Colombia, Canada, and Ecuador. It produces oil, natural gas, and natural gas liquids. Gran Tierra has assembled a diversified, high-quality asset base that is fully operated in Colombia and Ecuador and partly in Canada. The company operates various blocks in Colombia and Ecuador, spanning three basins. It also has contiguous areas in Alberta, Canada, spanning various gross acres across the Western Canadian Sedimentary Basin. The company's reportable segments are Colombia, Ecuador, Canada, and Other. A majority of its revenue is derived from its operations in Colombia.

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. The company derives its revenue from United States.

Share on Social Networks: